Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Backers
1
Mérieux Equity Partners
Momentum
0/100
no fresh signals
Tractionpublic signals, read monthly
Web presence
top 8%
of 133.2M domains by links, Common Crawl
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
Company Focus Our mission is to pioneer early lung cancer detection and save lives. Lung cancer is the second most common cancer worldwide…
VitalTechVenture round $9M · 2 yr ago • Founded 2019 • 51-200 employees
Discover VitalTech's virtual care solutions: optimizing efficiency, improving patient outcomes, and increasing reimbursements.
DELFI DiagnosticsVenture round $225M · 4 yr ago • Founded 2019 • 51-200 employees • 5 roles
FirstLook Lung is a blood-based test that helps identify lung cancer risk before or alongside LDCT, for USPSTF-eligible adults. From DELFI…
Skip to the content About Reveal-Dx is a Seattle-based software company whose vision is to dramatically improve lung cancer outcomes. We do…
CereVasc eShunt® Device | Under Development for HydrocephalusVenture round $11.1M · 6 yr ago • Founded 2020 • 51-200 employees
The CereVasc eShunt® device is intended to improve patient outcomes and redefine the treatment of communicating hydrocephalus.
SmarterdxSeries B $50M · 2 yr ago • Founded 2020 • 51-200 employees • 4 roles
SmarterDx is a leading provider of artificial intelligence (AI)-powered solutions for healthcare. Our platform uses AI to analyze large…

Overview

The biopsy and treatment of lung cancer in a single hospital visit – reducing time-to-treat from weeks to minutes; relieving hospital pressures, improving patient outcomes.